This bill establishes new regulations regarding medication abortions in Iowa, focusing on informed consent and the dispensing of abortion-inducing drugs. It defines key terms such as "abortion," "abortion-inducing drug," and "medication abortion," and mandates that facilities performing medication abortions must post a conspicuous sign informing patients about the potential ineffectiveness of medication abortions and the possibility of reversing their effects. Additionally, it requires physicians to obtain written certification from patients, confirming they have been informed of the risks associated with medication abortions and the potential for reversal, prior to the procedure.

Furthermore, the bill stipulates that mifepristone, a drug used in medication abortions, can only be dispensed directly to patients in a healthcare setting. The Department of Health and Human Services is tasked with providing informational materials on the possibility of reversing medication abortions. Non-compliance by physicians can lead to disciplinary action, and the bill clarifies that it does not create or recognize a right to an abortion nor impose liability on women undergoing the procedure.